Descrizione

An autoimmune disease is a condition arising from an abnormal immune response to a functioning body part. There are around 80 different autoimmune disorders ranging in severity from mild to disabling, depending on which system of the body is under attack and to what degree. The global autoimmune disease diagnostics market is set to grow by US$ 2 miliardi durante 2021-2027, crescendo ad un tasso di crescita annuale composto (CAGR) Di 5.1% durante il periodo di previsione, secondo la società di dati e analisi StrategyHelix. Growing patient awareness levels concerning autoimmune diseases, presence of favorable government initiatives, improved laboratory automation, rise in the geriatric population and growing prevalence of obesity, tipo 1 diabetes and other chronic diseases are expected to boost the market growth in the coming years.

Il rapporto fornisce dati aggiornati sulle dimensioni del mercato per il periodo 2017-2020 e previsione a 2027 covering key market aspects like sales value for autoimmune disease diagnostics. The global autoimmune disease diagnostics market is segmented on the basis of type, gender, tecnologia, e regione. Per tipo, it is categorized into systemic autoimmune disease diagnostics, and localized autoimmune disease diagnostics. The localized autoimmune disease diagnostics segment held the largest market share in 2020. By gender, the autoimmune disease diagnostics market is divided into female, and male. The female segment accounted for the largest market share in 2020. Based on technology, the autoimmune disease diagnostics market is divided into enzyme-linked immunosorbent assay (ELISA), indirect immunofluorescence (IIF), immunoblot, multiplex immunoassays, e altri.

The systemic autoimmune disease diagnostics market is further segmented into rheumatoid arthritis, psoriasis/psoriatic arthritis, systemic lupus erythematosus, multiple sclerosis, e altri. Among them, rheumatoid arthritis segment held the largest market share in 2020. The localized autoimmune disease diagnostics market is further segmented into inflammatory bowel disease, tipo 1 diabetes, thyroid, e altri. Tra questi, thyroid segment held the largest market share in 2020.

The report has profiled some of the key players of the market such as Abbott Laboratories, Beckman Coulter Inc. (Danaher Corporation), Becton Dickinson and Company, bioMerieux Inc., Bio-Rad AbD Serotec Limited, Bristol Myers Squibb (BMS), EUROIMMUN AG (PerkinElmer Inc.), F. Hoffmann-La Roche AG, Immuno Concepts Inc., INOVA Diagnostics Inc., Siemens Healthineers AG, SQI Diagnostics Inc., Thermo Fisher Scientific Inc., Trinity Biotech plc (IMMCO Diagnostics Inc).

Il rapporto è una risorsa inestimabile per le aziende e le organizzazioni attive in questo settore. It provides a cohesive picture of the autoimmune disease diagnostics market to help drive informed decision making for industry executives, decisori politici, accademico, e analisti.

Ambito del rapporto

Tipo: systemic autoimmune disease diagnostics, and localized autoimmune disease diagnostics
Genere: female, and male
Tecnologia: enzyme-linked immunosorbent assay (ELISA), indirect immunofluorescence (IIF), immunoblot, multiplex immunoassays, e altri
Regione: Nord America, Asia Pacifico, Europa, and Rest of the World (ROW)
Anni considerati: la presente relazione copre il periodo 2017 A 2027

Principali vantaggi per gli stakeholder

Get a comprehensive picture of the global autoimmune disease diagnostics market
Identificare le strategie regionali e le priorità strategiche sulla base di dati e analisi locali
Individuare i settori in crescita e le tendenze per gli investimenti
Understand what the future of the global autoimmune disease diagnostics market looks like
Identificare il panorama competitivo e la finestra di opportunità

Sommario

1. Definizione del mercato
2. Metodologia di ricerca
3. Dati di mercato & Veduta
3.1 Valore di mercato
3.2 Previsione del valore di mercato
4. Autoimmune Disease Diagnostics Market by Type
4.1 Systemic Autoimmune Disease Diagnostics
4.2 Localized Autoimmune Disease Diagnostics
5. Autoimmune Disease Diagnostics Market by Gender
5.1 Female
5.2 Male
6. Autoimmune Disease Diagnostics Market by Technology
6.1 Enzyme-Linked Immunosorbent Assay (Elisa)
6.2 Indirect Immunofluorescence (Iif)
6.3 Immunoblot
6.4 Multiplex Immunoassays
6.5 Altri
7. Autoimmune Disease Diagnostics Market by Region
7.1 Nord America
7.2 Asia Pacifico
7.3 Europa
7.4 Rest Of The World (Row)
8. Profili aziendali
8.1 Abbott Laboratories
8.2 Beckman Coulter Inc. (Danaher Corporation)
8.3 Becton, Dickinson and Company
8.4 bioMerieux, Inc.
8.5 Bio-Rad AbD Serotec Limited
8.6 Bristol Myers Squibb (BMS)
8.7 EUROIMMUN AG (PerkinElmer, Inc.)
8.8 F. Hoffmann-La Roche AG
8.9 Immuno Concepts, Inc.
8.10 INOVA Diagnostics, Inc.
8.11 Siemens Healthineers AG
8.12 SQI Diagnostics, Inc.
8.13 Thermo Fisher Scientific Inc.
8.14 Trinity Biotech plc (IMMCO Diagnostics Inc)
9. Appendice
9.1 Informazioni su StrategyHelix
9.2 Disclaimer